| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.70B | 11.02B | 10.73B | 8.78B | 6.77B | 6.22B |
| Gross Profit | 6.94B | 6.89B | 6.92B | 5.72B | 4.38B | 4.06B |
| EBITDA | 2.54B | 2.63B | 2.87B | 2.46B | 1.75B | 1.96B |
| Net Income | 1.98B | 1.89B | 2.23B | 1.75B | 1.40B | 1.38B |
Balance Sheet | ||||||
| Total Assets | 14.98B | 17.11B | 16.74B | 15.61B | 13.81B | 13.53B |
| Cash, Cash Equivalents and Short-Term Investments | 5.13B | 6.18B | 6.05B | 4.68B | 4.56B | 5.79B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.28B | 2.23B | 2.26B | 2.34B | 1.58B | 1.61B |
| Stockholders Equity | 13.70B | 14.88B | 14.48B | 13.27B | 12.23B | 11.91B |
Cash Flow | ||||||
| Free Cash Flow | 1.21B | 1.89B | 1.38B | 2.24B | 1.48B | 1.67B |
| Operating Cash Flow | 1.36B | 1.90B | 1.63B | 2.28B | 1.49B | 1.69B |
| Investing Cash Flow | 126.43M | 368.45M | 177.71M | -675.34M | -1.42B | -398.21M |
| Financing Cash Flow | -933.56M | -1.51B | -1.26B | -682.46M | -793.09M | -684.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥22.87B | -13.94 | ― | 3.79% | 2.69% | -13.40% | |
78 Outperform | ¥10.71B | 13.11 | ― | 1.72% | 3.95% | 4.50% | |
70 Outperform | ¥33.01B | 30.08 | ― | 0.39% | 41.23% | 50.13% | |
70 Outperform | ¥25.82B | 24.11 | ― | 5.45% | 21.90% | 0.46% | |
64 Neutral | ¥16.42B | 65.84 | ― | 3.66% | 8.62% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | ¥10.87B | 426.22 | ― | 2.24% | 32.39% | -127.51% |